Description
COVID-19 TEST KITS
First action · last action
2022-02-15 · 2023-09-20
Transactions
5
First transaction's obligation
$74,998,080
Base + all options value (sum of deltas)
$149,996,025
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY (FAR 6.302-2)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-02-15+$74,998,080= $74,998,080
- Mod P000012022-03-01+$0= $74,998,080
- Mod P000022022-05-05-$135= $74,997,945
- Mod P000032022-05-20+$0= $74,997,945
- Mod P000042023-09-20-$55,699= $74,942,246
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-02-15 | +$74,998,080 | $74,998,080 | COVID-19 TEST KITS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-03-01 | +$0 | $74,998,080 | COVID-19 TEST KITS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-05-05 | −$135 | $74,997,945 | COVID-19 TEST KITS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-05-20 | +$0 | $74,997,945 | COVID-19 TEST KITS |
| Mod P00004· FUNDING ONLY ACTION | 2023-09-20 | −$55,699 | $74,942,246 | COVID-19 TEST KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6550 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X21N0105 | CEPHEID | SAC FREDERICK (36C10X) | $27,353,200 | FY2021 |
| 36C10X21N0103 | CEPHEID | SAC FREDERICK (36C10X) | $148,585 | FY2021 |
| 36C10X21N0086 | CEPHEID | SAC FREDERICK (36C10X) | $594,340 | FY2021 |
| 36C10X21N0066 | CEPHEID | SAC FREDERICK (36C10X) | $297,170 | FY2021 |
| 36C10X21N0056 | CEPHEID | SAC FREDERICK (36C10X) | $33,028,835 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C10X22C0007_3600_-NONE-_-NONE- · retrieved 2026-09-26.